证券代码：600755 证券简称：厦门国贸 编号：2025-37 投资者可于 2025 年 5 月 16 日（星期五） 至 5 月 22 日（星期四）16:00 前 登 录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公 司 邮 箱 （zqswb@itg.com.cn）进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 厦门国贸集团股份有限公司（以下简称"公司"）已分别于 2025 年 4 月 23 日和 2025 年 4 月 30 日在上海证券交易所网站（http://www.sse.com.cn）披露了公 司 2024 年年度报告和 2025 年第一季度报告。为便于广大投资者更全面深入地了 解情况，促进公司与投资者互动交流，公司计划于 2025 年 5 月 23 日上午 10:00-11:30 举行 2024 年度暨 2025 年第一季度业绩说明会，就投资者关心的问题 进行交流。 厦门国贸集团股份有限公司 关于召开2024年度暨2025年第一季度 业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏 ...

证券代码：600755 证券简称：厦门国贸 公告编号：2025-41 厦门国贸集团股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东大会类型和届次 2024年年度股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 5 日 14 点 30 分 召开地点：福建省厦门市湖里区仙岳路 4688 号国贸中心 5 层会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 5 日 至2025 年 6 月 5 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互 联网投票平台的投票时间为股东大 ...

证券代码：600755 证券简称：厦门国贸 编号：2025-39 厦门国贸集团股份有限公司 监事会决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 根据《公司法》和《公司章程》等有关规定，公司监事会同意提名吴晓强先生为公 司第十一届监事会监事候选人，任期自股东大会选举之日起至公司第十一届监事会任期 届满之日止。（吴晓强先生简历附后） 表决结果：同意 3 票、反对 0 票、弃权 0 票。 该议案尚需提交公司股东大会审议。 特此公告。 厦门国贸集团股份有限公司监事会 厦门国贸集团股份有限公司（下称"公司"）第十一届监事会 2025 年度第四次会议 通知于 2025 年 5 月 15 日以书面方式送达全体监事，全体监事一致同意豁免本次会议通 知时限要求，本次会议于 2025 年 5 月 15 日以通讯方式召开。会议应到监事 3 人，实到 监事 3 人。会议由监事会主席马陈华先生主持。本次会议的通知、召开及审议程序符合 《公司法》等法律法规及《公司章程》的有关规定。 二、监事会会议审议情况 与会监事经审 ...

证券代码：600755 证券简称：厦门国贸 编号：2025-38 厦门国贸集团股份有限公司 董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 厦门国贸集团股份有限公司（以下简称"公司"）第十一届董事会 2025 年度 第八次会议通知于 2025 年 5 月 15 日以书面方式送达全体董事，全体董事一致同 意豁免本次会议通知时限要求，本次会议于 2025 年 5 月 15 日以通讯方式召开。 本次会议应到董事 8 人，实到董事 8 人。会议由董事长高少镛先生主持，全体监 事列席了会议。会议的通知、召开及审议程序符合《公司法》等法律法规及《公 司章程》的规定。 本议案已经第十一届董事会提名委员会 2025 年度第四次会议审议通过。 具体内容详见公司同日披露的《厦门国贸集团股份有限公司关于董事辞职暨 增补董事的公告》（编号 2025-40）。 本议案尚需提交公司股东大会审议。 2.《关于召开公司 2024 年年度股东大会的议案》。 表决结果：同意 8 票、反对 0 票、弃权 0 票。 具体内容详 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [2][4][6] Core Views - The company experienced a significant decline in revenue and net profit in 2024 due to a reduction in supply chain business scale and asset impairment losses. However, the first quarter of 2025 shows signs of recovery in operating quality and profitability [4][9] - Future profitability is expected to rebound as non-recurring impairment losses decrease and core business profitability stabilizes [4][6] Summary by Sections Financial Performance - In 2024, the company reported operating revenue of RMB 354.44 billion, a decrease of 24.3% year-on-year, and a net profit attributable to shareholders of RMB 626 million, down 67.33% year-on-year [4][9] - For Q1 2025, the company achieved operating revenue of RMB 70.53 billion, a decline of 27.19% year-on-year, but a net profit of RMB 422 million, an increase of 2.76% year-on-year [4][9] Profitability Forecast - The adjusted net profit forecasts for 2025-2027 are RMB 1.27 billion, RMB 1.55 billion, and RMB 1.97 billion, representing growth rates of 103.6%, 21.8%, and 27.2% respectively. The expected EPS for these years are RMB 0.59, RMB 0.72, and RMB 0.91 [6][8] Business Strategy - The company is focusing on high-value-added services in its supply chain business and accelerating international expansion by establishing branches in countries like Vietnam and Germany [9] - The health technology segment showed strong performance with a revenue increase of 49.61% to RMB 1.10 billion, with significant overseas revenue contribution [9]

Investment Rating - The report maintains an "Accumulate" rating for the company [2][4][6] Core Views - The company experienced a significant decline in revenue and net profit in 2024 due to a reduction in supply chain business scale and asset impairment losses. However, the first quarter of 2025 shows signs of recovery in operating quality and profitability [4][9] - Future profitability is expected to rebound as non-recurring impairment losses decrease and core business profitability stabilizes [4][6] Financial Summary - In 2024, the company reported operating revenue of RMB 354.44 billion, a decrease of 24.30% year-on-year, and a net profit attributable to shareholders of RMB 626 million, down 67.33% [4][9] - For Q1 2025, the company achieved operating revenue of RMB 70.53 billion, a decline of 27.19% year-on-year, but a net profit of RMB 422 million, an increase of 2.76% [4][9] - The projected net profits for 2025-2027 are RMB 1.27 billion, RMB 1.55 billion, and RMB 1.97 billion, representing growth rates of 103.6%, 21.8%, and 27.2% respectively [6][8] Valuation Metrics - The report adjusts the earnings per share (EPS) forecast for 2025-2027 to RMB 0.59, RMB 0.72, and RMB 0.91, with corresponding price-to-earnings (PE) ratios of 10.9, 8.9, and 7.0 [6][8] - The company’s EBITDA for 2025 is projected at RMB 3.07 billion, with a significant recovery expected in subsequent years [8][9] Strategic Outlook - The company is focusing on enhancing its supply chain management and international expansion, with plans to establish branches in countries like Vietnam and Germany [9] - The health technology segment is expected to grow, with a 49.61% increase in revenue to RMB 1.10 billion in 2024 [9]

Group 1 - The company will participate in the "2024 Annual Report Performance Briefing and Investor Online Reception Day" organized by Xiamen Securities Regulatory Bureau, Xiamen Listed Companies Association, and Shenzhen Panorama Network Co., Ltd. on May 15, 2025 [1][4] - The event will be held in an online interactive format from 15:40 to 17:00 [1] - Investors can access the event through the "Panorama Roadshow" website, WeChat official account "Panorama Finance," or by downloading the Panorama Roadshow APP [1] Group 2 - Key participants from the company include Vice Chairman and President Cai Yingbin, Independent Director Peng Shuijun, Vice President and Board Secretary Fan Dan, and Vice President and Chief Financial Officer Zhou Chaohua [2] - Investors can submit questions via email by May 13, 2025, and the company will address common concerns during the briefing [2] - Investors can also log in to the "Panorama Roadshow" website during the event to participate and receive timely responses to their inquiries [2][3] Group 3 - The contact department for the event is the Securities Affairs Department, with a provided phone number and email for inquiries [3] - After the event, investors can view the event's proceedings and main content on the "Panorama Roadshow" website [3]

证券代码：600755 证券简称：厦门国贸 编号：2025-36 厦门国贸集团股份有限公司 关于参加厦门辖区上市公司2024年年报业绩说明会暨 投资者网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为进一步加强与投资者的互动交流，厦门国贸集团股份有限公司（以下简称 "公司"）将参加由厦门证监局、厦门上市公司协会与深圳市全景网络有限公司 联合举办的"厦门辖区上市公司 2024 年年报业绩说明会暨投资者网上集体接待日 活动"，现将相关事项公告如下： 一、活动的时间、方式、平台 活动时间：2025 年 5 月 15 日（星期四）15:40-17:00 三、投资者参与方式 1．投资者可于 2025 年 5 月 13 日（星期二）17:00 前将相关问题通过电子邮 件的方式发送至 zqswb@itg.com.cn，公司将在说明会上就投资者普遍关注的问题 进行回答。 活动方式：网络文字互动方式 活动平台：投资者可登录"全景路演"网站（http://rs.p5w.net），或关注微信 公众号："全景财经"，或下载全 ...

Group 1 - Xiamen Guomao Shipbuilding Co., Ltd. has been established with a registered capital of 60 million yuan [1] - The company is wholly owned by Xiamen Guomao and its legal representative is Lin Haiyu [1] - The business scope includes ship sales, leasing, supply chain management, import and export services, and various transportation services [1] Group 2 - The company is involved in both domestic and international shipping, including container and general cargo transportation [1] - It offers a wide range of services such as customs declaration, warehousing, and marine engineering equipment manufacturing [1] - The company is also engaged in ship management, repair, and training services for crew and pilots [1]

Summary of Key Points Core Viewpoint - In the recent five trading days (April 24 to April 30), significant shareholders of 17 companies increased their holdings, totaling 55.21 million shares and an investment of 474 million yuan, while 49 companies saw a reduction in holdings amounting to 4.909 billion yuan [1]. Group 1: Shareholder Activity - A total of 17 companies experienced significant shareholder increases, with a cumulative increase of 55.21 million shares and an investment of 474 million yuan [1]. - Among the companies with notable increases, Debon Holdings led with an increase of 9.5563 million shares and an investment of 13.132 million yuan, followed by China Aluminum with 17.3 million shares and 11.1 million yuan [1][2]. - The majority of the increased holdings were concentrated in the transportation and non-ferrous metals sectors, with 4 and 2 companies respectively [1]. Group 2: Market Performance - The average performance of stocks with increased holdings saw a decline of 0.71% over the five days, underperforming the Shanghai Composite Index during the same period [1]. - Notable gainers included Tongkun Co., with a rise of 3.13%, and Kangxin Materials, which increased by 2.02% [1][2]. - Conversely, stocks like Beibu Gulf Port and Debon Holdings experienced significant declines of 6.73% and 5.82% respectively [1][2]. Group 3: Fund Flow - Among the stocks with increased holdings, 9 experienced net inflows of main funds, with Renfu Pharmaceutical seeing the highest net inflow of 5.8 million yuan [2]. - In contrast, Beibu Gulf Port and Qiyi Er experienced the largest net outflows, with 205 million yuan and 61 million yuan respectively [2].